The world is linkurl:facing a crisis:; Bacteria have become linkurl:more and more resistant; to virtually all existing antibiotics, yet many companies are abandoning the field in favor of more lucrative medicines.
Ron Najafi
Image: NovaBay
People are proposing various solutions, such as offering financial incentives to the pharmaceutical industry to linkurl:spur the development of vitally needed antibiotics.; But along with creating new drugs, we can get more life from our existing antibiotics and maintain their utility. As the head of a company focused on the development of compounds to treat and prevent a wide range of infections without causing bacterial resistance, this is an issue I find both fascinating and vitally important. In my opinion, there are five ways we can extend the functional life of our antibiotic arsenal.1. Do the obvious In a recent linkurl:New York Times; article, linkurl:Ramanan Laxminarayan,; director of the linkurl:Extending the Cure; project on...
E. coli2. Assess the impact
NovaBay scientist at work
Image: NovaBay
3. Explore entirely different drugs4. Inactivate multiple essential targets5. Encourage and incentivize the industryRon Najafi, PhD is chairman and CEO of linkurl:NovaBay Pharmaceuticals, Inc (NBY).,; an Emeryville, California-based biotechnology company developing anti-infective compounds for the treatment and prevention of antibiotic-resistant infections. He can be reached at

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?